CoreCap Advisors LLC Buys Shares of 1,186 Axon Enterprise, Inc. (NASDAQ:AXON)

CoreCap Advisors LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXONGet Rating) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,186 shares of the biotechnology company’s stock, valued at approximately $110,000.

A number of other hedge funds also recently added to or reduced their stakes in AXON. Trexquant Investment LP acquired a new position in shares of Axon Enterprise during the second quarter valued at $1,074,000. Deutsche Bank AG increased its holdings in shares of Axon Enterprise by 55.6% during the second quarter. Deutsche Bank AG now owns 25,876 shares of the biotechnology company’s stock valued at $2,411,000 after purchasing an additional 9,249 shares during the period. Bank of Montreal Can increased its holdings in shares of Axon Enterprise by 7.0% during the second quarter. Bank of Montreal Can now owns 8,953 shares of the biotechnology company’s stock valued at $865,000 after purchasing an additional 587 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of Axon Enterprise by 1.0% during the second quarter. JPMorgan Chase & Co. now owns 133,463 shares of the biotechnology company’s stock valued at $12,435,000 after purchasing an additional 1,341 shares during the period. Finally, Clarius Group LLC acquired a new position in shares of Axon Enterprise during the second quarter valued at $335,000. 78.44% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on AXON. StockNews.com began coverage on Axon Enterprise in a report on Wednesday, October 12th. They set a “hold” rating on the stock. Northland Securities lifted their target price on Axon Enterprise from $140.00 to $160.00 in a report on Wednesday, November 9th. Robert W. Baird lifted their price target on Axon Enterprise to $170.00 in a research note on Tuesday, November 15th. Credit Suisse Group lifted their price target on Axon Enterprise from $142.00 to $152.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 9th. Finally, Morgan Stanley lifted their price target on Axon Enterprise from $120.00 to $130.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 9th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $168.25.

Axon Enterprise Trading Up 0.2 %

Shares of NASDAQ AXON opened at $187.75 on Friday. Axon Enterprise, Inc. has a one year low of $82.49 and a one year high of $193.85. The firm has a market capitalization of $13.36 billion, a PE ratio of 129.48 and a beta of 0.70. The company has a current ratio of 2.79, a quick ratio of 2.39 and a debt-to-equity ratio of 0.01. The business has a 50-day moving average price of $145.59 and a two-hundred day moving average price of $123.88.

Insiders Place Their Bets

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,271 shares of the firm’s stock in a transaction dated Monday, September 26th. The stock was sold at an average price of $112.42, for a total transaction of $142,885.82. Following the completion of the sale, the insider now directly owns 201,490 shares in the company, valued at approximately $22,651,505.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Axon Enterprise news, Director Matthew R. Mcbrady sold 1,699 shares of the firm’s stock in a transaction dated Friday, November 11th. The stock was sold at an average price of $182.88, for a total transaction of $310,713.12. Following the completion of the sale, the director now directly owns 5,651 shares in the company, valued at approximately $1,033,454.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jeffrey C. Kunins sold 1,271 shares of Axon Enterprise stock in a transaction dated Monday, September 26th. The shares were sold at an average price of $112.42, for a total value of $142,885.82. Following the sale, the insider now owns 201,490 shares of the company’s stock, valued at $22,651,505.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 10,833 shares of company stock worth $1,399,754. 6.90% of the stock is currently owned by company insiders.

About Axon Enterprise

(Get Rating)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.